• About Us
    • Our Company
    • Our People
  • Our Science
    • Our Science
    • Precise Antibody Engineering
    • Cytokine-Fusion Antibody
    • Novel T cell Targets
  • Pipeline
    • Pipeline
    • MMB101
    • MMB102
    • MFA011
  • Partnering
  • News
  • About Us
    • Our Company
    • Our People
  • Our Science
    • Our Science
    • Precise Antibody Engineering
    • Cytokine-Fusion Antibody
    • Novel T cell Targets
  • Pipeline
    • Pipeline
    • MMB101
    • MMB102
    • MFA011
  • Partnering
  • News

  • About us
    • Our Company
    • Our People
  • Contact
  • Home
  • Our Science
    • Cytokine-Fusion Antibody
    • Novel T cell Targets
    • Precise Antibody Engineering
  • Partnering with Us
  • Pipeline
    • MFA011
    • MMB101
    • MMB102

News

2024-10-21

MediMabBio Selected for the “Korea-Singapore Technology Exchange and Investment Promotion Forum” Hosted by the Korea Techno-Venture Foundation

2024-08-27

MediMabBio Selected for 2024 Scale-Up TIPS Program

2024-07-11

MediMabBio Joins KHIDI’s Vaccine Corporate Council

2024-05-24

MediMabBio to Present Groundbreaking Research at EACR2024

2024-04-30

MediMabBio signs MoU with PDC*line Pharma to collaborate on cancer immunotherapy

2024-01-30

MediMabBio Selected for Celltrion’s Open Innovation Program

2023-05-25

MediMabBio Selected for Ministry of SME’s and Startups TIPS Overseas Marketing Funding

2022-01-01

MediMabBio selected as the ‘Best Employer’ by Seongnam City Council

2021-10-28

MediMabBio takes first step towards commercialization with Thermo Fisher CDMO Contract

2021-06-28

MediMabBio has made a collaboration deal with University Hospitals Birmingham for immunotherapy cancer drug development

  • 1
  • 2
  • »

  • Home
  • Our Company
    • Our Company
    • Our People
  • Our Science
    • Our Science
    • Precise Antibody Engineering
    • Cytokine-Fusion Antibody
    • Novel T cell Targets
  • Pipeline
    • Pipeline
    • MMB101
    • MMB102
    • MFA011
  • Partnering with Us
  • News
  • Contact

#721, 54, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea, 13449 Tel. 82-(0)31-623-2100 Fax. 82-(0)31-751-2101 Email. info@medimabbio.com

©MEDIMABBIO. ALL RIGHTS RESERVED.